Verrica Pharmaceuticals Inc (VRCA)
7.61
-0.04
(-0.52%)
USD |
NASDAQ |
May 08, 16:00
7.60
-0.01
(-0.13%)
Pre-Market: 20:00
Verrica Pharmaceuticals Price to Book Value: 16.33 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 16.33 |
| May 07, 2024 | 16.42 |
| May 06, 2024 | 15.69 |
| May 03, 2024 | 15.58 |
| May 02, 2024 | 14.51 |
| May 01, 2024 | 14.70 |
| April 30, 2024 | 14.95 |
| April 29, 2024 | 15.35 |
| April 26, 2024 | 14.75 |
| April 25, 2024 | 14.27 |
| April 24, 2024 | 14.57 |
| April 23, 2024 | 14.70 |
| April 22, 2024 | 14.57 |
| April 19, 2024 | 14.98 |
| April 18, 2024 | 14.81 |
| April 17, 2024 | 15.15 |
| April 16, 2024 | 15.03 |
| April 15, 2024 | 14.85 |
| April 12, 2024 | 14.75 |
| April 11, 2024 | 15.18 |
| April 10, 2024 | 15.43 |
| April 09, 2024 | 15.13 |
| April 08, 2024 | 15.03 |
| April 05, 2024 | 14.45 |
| April 04, 2024 | 13.78 |
| Date | Value |
|---|---|
| April 03, 2024 | 13.22 |
| April 02, 2024 | 12.64 |
| April 01, 2024 | 12.71 |
| March 28, 2024 | 12.71 |
| March 27, 2024 | 12.13 |
| March 26, 2024 | 11.42 |
| March 25, 2024 | 10.86 |
| March 22, 2024 | 10.75 |
| March 21, 2024 | 10.84 |
| March 20, 2024 | 10.65 |
| March 19, 2024 | 10.17 |
| March 18, 2024 | 10.20 |
| March 15, 2024 | 10.30 |
| March 14, 2024 | 10.52 |
| March 13, 2024 | 11.08 |
| March 12, 2024 | 11.16 |
| March 11, 2024 | 11.18 |
| March 08, 2024 | 10.75 |
| March 07, 2024 | 10.43 |
| March 06, 2024 | 10.67 |
| March 05, 2024 | 11.03 |
| March 04, 2024 | 11.91 |
| March 01, 2024 | 11.91 |
| February 29, 2024 | 11.31 |
| February 28, 2024 | 12.28 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.919
Minimum
Nov 09 2022
16.42
Maximum
May 07 2024
6.038
Average
5.461
Median
Feb 06 2023
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.964 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7198 |
| Theriva Biologics Inc | 0.1944 |
| Oragenics Inc | 3.441 |
Price to Book Value Related Metrics
| PS Ratio | 67.33 |
| PEG Ratio | -0.0649 |
| Price | 7.61 |
| Earnings Yield | -19.32% |
| Market Cap | 322.82M |
| PEGY Ratio | -0.0649 |